Analyzing the Price-to-Earnings Ratio of Iovance Biotherapeutics Inc (IOVA)
The 36-month beta value for IOVA is also noteworthy at 0.63. There are mixed opinions on the stock, with 4 analysts rating it as a
The 36-month beta value for IOVA is also noteworthy at 0.63. There are mixed opinions on the stock, with 4 analysts rating it as a
The stock price of Iovance Biotherapeutics Inc (NASDAQ: IOVA) has dropped by -1.96 compared to previous close of 13.53. Despite this, the company has seen
The stock price of Iovance Biotherapeutics Inc (NASDAQ: IOVA) has surged by 5.11 when compared to previous closing price of 14.10, but the company has
Iovance Biotherapeutics Inc (NASDAQ: IOVA)’s stock price has decreased by -2.82 compared to its previous closing price of 14.53. However, the company has seen a
Moreover, the 36-month beta value for IOVA is 0.62. Analysts have varying opinions on the stock, with 4 analysts rating it as a “buy,” 3
In the past week, IOVA stock has gone down by -11.40%, with a monthly gain of 45.65% and a quarterly surge of 89.25%. The volatility
© 2024, Fueled by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.